TY  - JOUR
AU  - Rubini-Costa, Ricardo
AU  - Bermudez-Jimenez, Francisco
AU  - Rivera-Lopez, Ricardo
AU  - Sola-Garcia, Elena
AU  - Nagib-Raya, Hadi
AU  - Moreno-Escobar, Eduardo
AU  - Angel Lopez-Zuniga, Miguel
AU  - Briones-Traves, Adela
AU  - Sanz-Herrera, Francisco
AU  - Miguel Sequi-Sabater, Jose
AU  - Luis Romero-Cabrera, Juan
AU  - Maillo-Seco, Javier
AU  - Fernandez-Vazquez, Felipe
AU  - Rivadeneira-Ruiz, Maria
AU  - Lopez-Valero, Lucas
AU  - Gomez-Navarro, Carlos
AU  - Antonio Aparicio-Gomez, Jose
AU  - Lopez, Miguel Alvarez
AU  - Tercedor, Luis
AU  - Molina-Jimenez, Maria
AU  - Macias-Ruiz, Rosa
AU  - Jimenez-Jaimez, Juan
PY  - 2022
DO  - 10.1016/j.medcli.2021.06.015
SN  - 0025-7753
UR  - https://hdl.handle.net/10668/24980
T2  - Medicina clinica
AB  - Introduction and purpose: Atrial fibrillation (AF) is common in patients admitted with severe COVID19. However, there is limited data about the management of chronic anticoagulation therapy in these patients. We assessed the anticoagulation and...
LA  - en
PB  - Elsevier espana slu
KW  - COVID-19
KW  - Atrial fibrillation
KW  - Major bleeding
KW  - Mortality
KW  - Anticoagulation
KW  - Outcomes
KW  - Interruption
KW  - Covid-19
KW  - Disease
TI  - Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection
TY  - research article
VL  - 158
ER  -